Northwestern scientists have discovered that the organization of a cell’s genetic material dictates cancer’s ability to adapt, according to a recent study published in the Proceedings of the National Academy of Sciences.
A multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.
A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.
Northwestern Medicine scientists have discovered how a subset of immune cells are essential for successful organ transplantation acceptance, according to a recent study published in The Journal of Clinical Investigation.
At Fourth Presbyterian Church in Chicago, first-year medical students donned their white coats for the first time and welcomed the official start of the academic year at Founders’ Day on August 8.
Northwestern scientists have created a free online tool that calculates a person’s “heart age” based on their risk for cardiovascular disease using routine health data, according to a study published in JAMA Cardiology.
Scientists have implemented a novel gene-editing approach that may be an effective treatment for alternating hemiplegia of childhood (AHC), a rare neurodevelopmental disorder in children, according to a recent study published in Cell.
Investigators led by Navdeep Chandel, PhD, have discovered how mitochondrial metabolism supports T-cell proliferation and also prevents T-cell exhaustion in cancer and chronic infection, according to a recent study published in Nature Immunology.
Investigators led by Francesca Elizabeth Duncan, PhD, have discovered new molecular mechanisms that enable specialized immune cells to cause ovarian aging and functional decline, according to a recent study published in PLOS Biology.
A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a diverse patient cohort more accurately than current models, according to a recent study published in Nature Medicine.